Advertisement

Topics

NICE reverses decision, backs Roche's Kadcyla for breast cancer indication

05:40 EDT 19 Jun 2017 | SmartBrief

Roche Holding's Kadcyla, or trastuzumab emtansine, has been recommended by the National Institute of Health and Care Excellen -More

Original Article: NICE reverses decision, backs Roche's Kadcyla for breast cancer indication

NEXT ARTICLE

More From BioPortfolio on "NICE reverses decision, backs Roche's Kadcyla for breast cancer indication"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...